Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07386548 · ClinicalTrials.gov registry record · NA
Biologic Injection For Adults With Lumbar Disc Herniation
A NA study, sponsored by Weill Medical College of Cornell University.
- Not yet
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT07386548 is a NA study that has not yet begun recruiting, run by Weill Medical College of Cornell University. The registered enrollment target is 90 participants.
The verdict
NCT07386548, a NA study, has not yet begun recruiting, sponsored by Weill Medical College of Cornell University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to find out whether adding a bone-marrow aspirate concentrate (BMAC) injection during surgery can improve recovery in adults undergoing lumbar microdiscectomy for a lumbar disc herniation. The main questions it aims to answer are: * Does the BMAC injection lead to better disc tissue health after surgery (as seen on MRI scans)? * Does the BMAC injection lead to greater improvement in pain and disability compared to surgery alone? Participants will be adults aged 18 and older who are scheduled for lumbar microdiscectomy surgery. Researchers will compare one group of participants receiving the standard-of-care surgery plus the BMAC injection with another group receiving the same surgery without the injection to see if the injection offers added benefit. Participants will: * Have surgery (microdiscectomy) with or without the injection. * Complete pain and disability questionnaires at several times over 2 years. * Undergo MRI scans at baseline and follow-up to assess disc structure and tissue health. * Provide samples of leftover disc or bone-marrow tissue (as applicable) from surgery for analysis.
Interventions
- OTHER Bone Marrow Aspirate Concentrate (BMAC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2030-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07386548
The ClinicalTrials.gov registry entry for NCT07386548 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bone Marrow Aspirate Concentrate (BMAC) is the first listed.
NCT07386548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07386548 about?
NCT07386548 is a clinical study titled "Biologic Injection For Adults With Lumbar Disc Herniation". The goal of this clinical trial is to find out whether adding a bone-marrow aspirate concentrate (BMAC) injection during surgery can improve recovery in adults undergoing lumbar microdiscectomy for a lumbar disc herniation. The main questions it aims to answer are: * Does the BMAC injection lead t...
What is the current status of trial NCT07386548?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2026-05-01. Estimated completion is 2030-12.
What interventions are being tested in trial NCT07386548?
The interventions under investigation include: Bone Marrow Aspirate Concentrate (BMAC) (OTHER).
Who is sponsoring clinical trial NCT07386548?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.